Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005900 |
---|---|
Receipt number | R000006931 |
Scientific Title | Phase II study of combination chemotherapy with TS-1/irinotecan and bevacizumab as second-line therapy in patient with K-RAS mutation-type metastatic colorectal cancer |
Date of disclosure of the study information | 2011/07/01 |
Last modified on | 2014/01/09 14:00:46 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/07/01 14:03:09 | ||
2 | Update | 2013/08/01 11:54:34 | Tel1 Email1 |
|
3 | Update | 2014/01/09 14:00:46 | TEL Last name of contact person Last name of contact person Address Address TEL |